An advanced method for quantitative measurements of cholesterol crystallization

Area of Science:

• Biomedical Engineering
• Cell Biology
• Cardiovascular Research

Background:

• Cholesterol crystallization in atherosclerotic plaques accelerates rupture, a critical event with limited preventive treatments.
• Current experimental models lack quantitative analysis and bioactivity screening capabilities for cholesterol crystal formation.

Purpose of the Study:

• To develop an in vitro human cell model for cholesterol crystallization.
• To integrate quantitative analysis and real-time imaging of crystal formation.

Main Methods:

• Utilized acetylated low-density lipoprotein (AcLDL) and 7-ketocholesterol for foam cell induction in THP-1 monocytes.
• Employed advanced confocal and polarizing microscopy for quantitative analysis of cholesterol crystals.
• Tested the model's utility with cholesterol-lowering drug lovastatin and ursodeoxycholic acid (UDCA).

Main Results:

• The lipid-loaded THP-1 cell model demonstrated significantly higher cholesterol crystal formation compared to untreated groups.
• Lovastatin and UDCA were shown to influence distinct aspects of cholesterol crystal formation.
• The model successfully quantifies cholesterol crystallization and allows for drug effect assessment.

Conclusions:

• The developed in vitro THP-1 monocyte model offers an effective platform for pre-clinical research on cholesterol crystallization.
• This model facilitates the screening of therapeutic compounds to attenuate or prevent cholesterol crystallization.
• Enables quantitative analysis and real-time imaging of cholesterol crystal formation for drug discovery.